These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 25089569)
1. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity. Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569 [TBL] [Abstract][Full Text] [Related]
2. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667 [TBL] [Abstract][Full Text] [Related]
3. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364 [TBL] [Abstract][Full Text] [Related]
4. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762 [TBL] [Abstract][Full Text] [Related]
5. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma. Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977 [TBL] [Abstract][Full Text] [Related]
6. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1. Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781 [TBL] [Abstract][Full Text] [Related]
7. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer. Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379 [TBL] [Abstract][Full Text] [Related]
8. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway. Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620 [TBL] [Abstract][Full Text] [Related]
10. β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer. Chen CH; Wang SH; Liu CH; Wu YL; Wang WJ; Huang J; Hung JS; Lai IR; Liang JT; Huang MC Carcinogenesis; 2014 Jun; 35(6):1258-66. PubMed ID: 24403309 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation. Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707 [TBL] [Abstract][Full Text] [Related]
12. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells. Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1. Zhang L; Zhang T; Deng Z; Sun L Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185 [TBL] [Abstract][Full Text] [Related]
14. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism. Tang JC; Liu JH; Liu XL; Liang X; Cai XJ World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967 [TBL] [Abstract][Full Text] [Related]
15. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma. Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218 [TBL] [Abstract][Full Text] [Related]
16. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma. Li Y; Ren Z; Wang Y; Dang YZ; Meng BX; Wang GD; Zhang J; Wu J; Wen N Exp Cell Res; 2018 Sep; 370(2):373-382. PubMed ID: 29966664 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. Chen YL; Wang TH; Hsu HC; Yuan RH; Jeng YM PLoS One; 2013; 8(7):e70324. PubMed ID: 23922981 [TBL] [Abstract][Full Text] [Related]
18. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling. Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells. Ma WL; Jeng LB; Lai HC; Liao PY; Chang C Cancer Lett; 2014 Aug; 351(1):64-71. PubMed ID: 24944078 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma. Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]